Skip to main content

Table 4 The total costs of MS, in euros per patient per year, for the sample studied (N = 200) according to disability.

From: Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability

total costs (direct + indirect) 14327 18837 27869 41198 52841 24272
EDSS 0 1.0–3.0 3.5–5.5 6.0–7.0 7.5–9.5 mean
% patients on IM treatment our MS Unit 6 57 41 47 4 31
total costs adjusted by % of patients on IT in our MS Unit 7400 17589 23157 40273 48729 19589
% of global costs attributable to IT, in MS Unit 9 43 21 14 1 19
Disability -according to EDSS- mild   moderate   severe  
Global costs of MS in Poland (Orlewska et al., 2005) 6572   9362   11078  
   "Italy (Amato et al, 2002) 7463   23088   35975  
   "Sweden (Heriksson et al., 2001) 18787   36470   91986  
   "Germany (Kobelt et al., 2000) 20000   39000   61000  
   "United Kingdom (Kobelt et al., 2000) 20000   38000   41500  
   "France (Murphy et al., 1998) 8000   16000   22400  
   "Germany (Murphy et al., 1998) 9088   8224   22804  
   "United Kingdom (Murphy et al., 1998) 20500   27004   58488  
  1. Costs were calculated for patients classified in the 5 EDSS groups (columns 1 to 5) and for the whole sample, N = 200, (column 6). The total costs were adjusted by the percentage of patients on IT (immunomodulatory treatment) in our MS Unit in 2004. Costs that have been reported in other countries have been converted into euros and are described below (also according to patients' disability).